GSK, Other Pharma Cos. Seek Exclusion From New OECD Tax
GlaxoSmithKline, AstraZeneca, Johnson & Johnson and other pharmaceutical companies have lobbied the OECD to exclude the industry from its newly proposed consumer-based taxing system, arguing they don't directly sell products to...To view the full article, register now.
Already a subscriber? Click here to view full article